Keyless Cover Fob Key Rubber 2x Case CR-V Pilot Civic Accord Honda 2017 2018 for Car Remote Entry System Kits


  1. Home
  2. Keyless Cover Fob Key Rubber 2x Case CR-V Pilot Civic Accord Honda 2017 2018 for
  1. facebook
  2. twitter
  3. linkedin
  4. pinterest
2x Rubber Key Fob Cover Keyless Case for 2018 2017 Honda Accord Civic Pilot CR-V
Condition: New Brand:

Unbranded

Type: Universal Manufacturer Part Number:

QCT2019T

Fit for 1: 2018 2017 2016 2015 Honda Accord 5button smart key fob Fit for 3: 2018 2017 2016 2015 Honda CR-V 5button smart key fob
Fit for 2: 2018 2017 2016 2015 Honda Civic 5button smart key fob Fit for 4: 2018 2017 2016 2015 Honda Pilot 5button smart key fob
UPC:

885921737927












published on tue nov 09 2021

Keyless Cover Fob Key Rubber 2x Case CR-V Pilot Civic Accord Honda 2017 2018 for Car Remote Entry System Kits

gandhi, s., klein, j., robertson, a., pena-hernandez, m. a.,

Keyless Cover Fob Key Rubber 2x Case CR-V Pilot Civic Accord Honda 2017 2018 for Car Remote Entry System Kits

lin, m. j., roychoudhury, p., lu, p., fournier, j., ferguson, d., mohamed bakhash, s. a., muenker, m. c., srivathsan, a., wunder, e. a., kerantzas, n., wang, w., pyle, a., wilen, c. b., ogbuagu, o., greninger ,, a. l., iwasaki, a., schulz, w. l., ko, a. i.

sars-cov-2 remdesivir resistance mutations have been generated in vitro but have not been reported in patients receiving treatment with the antiviral agent. we present a case of an immunocompromised patient with acquired b-cell deficiency who developed an indolent, protracted course of sars-cov-2 infection. remdesivir therapy alleviated symptoms and produced a transient virologic response, but her course was complicated by recrudescence of high-grade viral shedding. whole genome sequencing identified a mutation, e802d, in the nsp12 rna-dependent rna polymerase which was not present in pre-treatment specimens. in vitro experiments demonstrated that the mutation conferred a ~6-fold increase in remdesivir ic50 but resulted in a fitness cost in the absence of remdesivir. sustained clinical and virologic response was achieved after treatment with casirivimab-imdevimab. although the fitness cost observed in vitro may limit the risk posed by e802d,

, this case illustrates the importance of monitoring for remdesivir resistance and the potential benefit of combinatorial therapies in immunocompromised patients with sars-cov-2 infection.

509
1.2k
EVGENIA.RU RSS